Provides an overview of a study testing the long term success of panmidronate disodium for injection (Aredia(R)) in multiple myeloma patients.

Article outlines Aredia's (pamidronate) approval by the FDA as a treatment for patients with osteolytic bone lesions of multiple myeloma.

Article presents statistics and clinical test results on Aredia's long term ability to reduce bone complications in multiple myeloma patients.

Journal article outlines findings that the bone protecting drug pamidronate (Aredia) helps reduce pain for women with spreading breast cancer.

Provides an overview of Aredia, a drug that causes deposition of calcium into the bones to prevent and treat bone lesions in cancer patients.